봉합사 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 상처 유형별, 최종 용도별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Suture Market Size, Share & Trends Analysis Report By Product, By Wound Type, By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,362,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,768,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,579,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

봉합사 시장 규모와 동향:

세계 봉합사 시장 규모는 2024년 57억 4,000만 달러로 추정되며, 2025-2030년 CAGR 6.09%로 성장할 것으로 예상됩니다. 이러한 시장 성장의 주요 요인은 정형외과, 심혈관외과, 일반외과 등 주요 전문 분야의 수술 건수 증가에 기인합니다.

봉합사의 기술 발전은 치유 결과를 개선하고 합병증을 줄이기 위해 봉합사 시장의 수요를 더욱 촉진하고 있습니다. 최소침습 수술과 정밀 수술의 인기가 높아짐에 따라 혁신적이고 효과적이며 환자 친화적인 상처 봉합 솔루션에 대한 수요는 예측 기간 동안 지속적으로 증가할 것으로 예상됩니다.

전 세계 수술 건수의 증가는 세계 봉합사 산업의 주요 수요 촉진요인입니다. 의료 시스템의 개선, 수술 기술의 발전, 인구 고령화로 인해 다양한 전문 분야의 수술이 증가하고 있습니다. 예를 들어, Global Survey 2023이 발표한 자료에 따르면 2023년 가장 흔한 수술은 지방흡입술로 220만 건 이상, 그 다음이 유방확대술, 눈꺼풀수술, 복부성형술, 코성형술 순입니다. 이러한 수술의 증가는 모두 상처 봉합과 수술 후 회복에 중요한 역할을 하는 봉합사 수요에 직접적인 영향을 미칩니다. 성형수술 외에도 제왕절개, 성형수술, 심혈관 중재술 등 필수적인 의료 시술이 봉합사 수요를 촉진하고 있어 시장 성장 잠재력은 더욱 확대되고 있습니다.

또한, 2023년 12월에 발표된 세계보건기구(WHO) 보고서에 따르면, 매년 약 119만 명이 교통사고로 인해 사망하고 있으며, 이러한 사고는 특히 5-29세 어린이와 젊은 성인의 사망 원인 중 가장 높은 비중을 차지하고 있습니다. 또한, 미국 노동통계국(BLS)과 국가안전위원회(National Safety Council)에 따르면, 2023년 민간 기업 고용주가 보고한 비 치명적 부상 및 질병은 약 260만 명으로 전년 대비 8.4% 감소했습니다. 교통 사고로 인한 부상 발생률이 높아지면서 시장 성장을 더욱 촉진하고 있습니다.

또한, 스포츠 관련 부상 발생률이 증가하고 있는 것도 시장 성장을 촉진하는 주요 요인 중 하나입니다. 예를 들어, 미국 안전위원회(NSC)에 따르면, 운동기구는 2023년 약 482,886건의 부상과 관련이 있으며, 모든 스포츠 및 레크리에이션 카테고리에서 부상의 주요 원인으로 작용할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 봉합사 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 세계의 봉합사 시장 분석 툴
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석
  • 가격 분석
  • 파이프라인 분석

제4장 세계의 봉합사 시장 : 제품 추정·동향 분석

• 세계의 봉합사 시장 : 제품 대시보드
• 세계의 봉합사 시장 : 제품 변동 분석
• 세계의 봉합사 시장 : 제품별, 수익별
• 외과용 봉합사
• 가시 봉합사(흡수성 전용)
• 장 봉합사
• 미세 봉합사

제5장 세계의 봉합사 시장 : 상처 유형 추정·동향 분석

• 세계의 봉합사 시장 : 상처 유형 대시보드
• 세계의 봉합사 시장 : 상처 유형 변동 분석
• 세계의 봉합사 시장 : 상처 유형별, 수익별
• 급성 상처
• 만성 상처

제6장 세계의 봉합사 시장 : 최종 용도 추정·동향 분석

• 세계의 봉합사 시장 : 최종 용도 대시보드
• 세계의 봉합사 시장 : 최종 용도 변동 분석
• 세계의 봉합사 시장 : 최종 용도별, 수익별
• 병원과 진료소
• 외래 수술 센터(ASC)
• 장기간병 시설
• 입원 재활 시설(IRF)
• 전문 간호 시설(SNF)
• 기타

제7장 세계의 봉합사 시장 : 유통 채널 추정·동향 분석

• 세계의 봉합사 시장 : 유통 채널 대시보드
• 세계의 봉합사 시장 : 유통 채널 변동 분석
• 세계의 봉합사 시장 : 유통 채널별, 수익별
• 기관 판매
• 소매 판매

제8장 세계의 봉합사 시장 : 지역 추정·동향 분석(제품, 상처 유형, 최종 용도별)

• 지역 대시보드
• 시장 규모와 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 주요 시장 진입 기업의 최근 동향과 영향 분석
• 기업/경쟁 분류
• 벤더 상황
  • 주요 판매대리점 및 채널 파트너 리스트
  • 주요 고객
  • 주요 기업의 시장 점유율 분석(2023년)
  • Medtronic
  • Lotus Surgicals Pvt Ltd
  • Dolphin Sutures
  • CONMED Corporation
  • Teleflex Incorporated
  • Ethicon(Johnson & Johnson Services, Inc.)
  • Smith+Nephew
  • Integra LifeSciences Corporation
  • Peter Surgical
  • Healthium Medtech Limited
  • Medline Industries, LP.
  • Dynarex Corporation
  • Corza Medical
  • Advanced Medical Solutions Group plc
  • Riverpoint Medical
  • B. Braun SE
  • Atramat
  • DemeTECH Corporation

ksm

영문 목차

영문목차

Suture Market Size & Trends:

The global suture market size was estimated at USD 5.74 billion in 2024 and is projected to grow at a CAGR of 6.09% from 2025 to 2030. This market growth is largely attributed to the rising number of surgical procedures across key specialties such as orthopedics, cardiovascular, and general surgery.

Technological advancements in suture materials aimed at improving healing outcomes and reducing complications further drive market demand. As minimally invasive and precision procedures grow in popularity, demand for innovative, effective, and patient-friendly wound closure solutions is expected to grow consistently throughout the forecast period.

The increasing number of surgeries worldwide is a primary demand driver in the global suture industry. Improving health systems, advancements in surgical technology, and an aging population have resulted in increased surgical procedures across various specialties. For instance, according to the data published by the Global Survey 2023, Liposuction was the most common surgery in 2023, with over 2.2 million, followed by breast augmentation, eyelid surgery, abdominoplasty, and rhinoplasty. All these increased procedures directly influence the demand for sutures, which play a significant role in wound closure and post-surgery recovery.Beyond cosmetic surgeries, the demand for sutures is also propelled by essential medical procedures such as cesarean sections, orthopedic surgeries, and cardiovascular interventions, further expanding the market's growth potential.

In addition, according to the World Health Organization (WHO) report published in December 2023, approximately 1.19 million people die each year due to road traffic crashes, making these incidents one of the leading causes of mortality, particularly among children and young adults aged 5 to 29 years. In addition, in 2023, private industry employers reported approximately 2.6 million nonfatal injuries and illnesses, reflecting a decline of 8.4% from the previous year, according to the Bureau of Labor Statistics (BLS) and the National Safety Council. The growing incidence of road accident injuries is further driving the market growth.

Furthermore, the growing incidence of sports-related injuries is one of the primary driving factors fueling market growth. For instance, according to the National Safety Council (NSC), exercise equipment was associated with approximately 482,886 injuries in 2023, marking it as the leading cause of injuries among all sports and recreation categories.

Global Suture Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global suture market report based on product, wound type, end-use, distribution channel, and region.

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Surgical Suture
  • Absorbable
  • Non-Absorbable
• Barbed Suture (only Absorbable)
  • Uni-directional barbed suture
  • Bi-directional barbed suture
• Gut Suture
• Microsutures
• Wound Type Outlook (Revenue, USD Million, 2018 - 2030)
• Acute Wounds
  • Surgical/ Procedure
  • Obstetrics / Gynecology
  • Colorectal
  • Cardiovascular
  • Bariatric and Upper GI
  • Plastic and Reconstructive Surgery
  • Urology
  • Hepato-pancreato-biliary (HPB)
  • Dermatology
  • Lacerations & Minor Cuts
• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Chronic Wounds
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals and Clinics
• Ambulatory Surgery Center (ASC)
• Long-term Care Facilities
• Inpatient Rehabilitation Facility (IRF)
• Skilled Nursing Facility (SNF)
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Institutional Sales
• Retail Sales
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Wound Type
  • 1.2.3. End Use
  • 1.2.4. Distribution Channel
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product and Wound Type outlook
  • 2.2.2. End Use and Distribution Channel
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Global Suture Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Suture Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Pipeline Analysis

Chapter 4. Global Suture Market: Product Estimates & Trend Analysis

• 4.1. Global Suture Market: Product Dashboard
• 4.2. Global Suture Market: Product Movement Analysis
• 4.3. Global Suture Market by Product, Revenue
• 4.4. Surgical Suture
  • 4.4.1. Surgical Suture market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.1. Absorbable Sutures
      • 4.4.1.1.1. Absorbable Sutures market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Non-Absorbable Sutures
      • 4.4.1.2.1. Non-Absorbable Sutures market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Barbed Suture (only Absorbable)
  • 4.5.1. Barbed Suture (only Absorbable) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.1. Uni-directional barbed suture
      • 4.5.1.1.1. Uni-directional barbed suture market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.2. Bi-directional barbed suture
      • 4.5.1.2.1. Bi-directional barbed suture market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Gut Suture
  • 4.6.1. Gut Suture market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Microsutures
  • 4.7.1. Microsutures market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Suture Market: Wound Type Estimates & Trend Analysis

• 5.1. Global Suture Market: Wound Type Dashboard
• 5.2. Global Suture Market: Wound Type Movement Analysis
• 5.3. Global Suture Market by Wound Type, Revenue
• 5.4. Acute Wounds
  • 5.4.1. Acute Wounds market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.1. Surgical/ Procedure
      • 5.4.1.1.1. Surgical/ Procedure market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.1.1. Obstetrics / Gynecology
      • 5.4.1.1.2. Obstetrics / Gynecology market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.2.1. Colorectal
      • 5.4.1.1.3. Colorectal market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.3.1. Cardiovascular
      • 5.4.1.1.4. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.4.1. Bariatric and Upper GI
      • 5.4.1.1.5. Bariatric and Upper GI market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.5.1. Plastic and Reconstructive Surgery
      • 5.4.1.1.6. Plastic and Reconstructive Surgery market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.6.1. Urology
      • 5.4.1.1.7. Urology market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.7.1. Hepato-pancreato-biliary (HPB)
      • 5.4.1.1.8. Hepato-pancreato-biliary (HPB) market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.8.1. Dermatology
      • 5.4.1.1.9. Dermatology market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.1.9.1. Others
      • 5.4.1.1.10. Others market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2. Lacerations & Minor Cuts
      • 5.4.1.2.1. Lacerations & Minor Cuts market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Chronic Wounds
  • 5.5.1.Chronic Wounds market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.1.1. Diabetic Foot Ulcers
    • 5.5.1.1.1. Diabetic Foot Ulcers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.1.2. Pressure Ulcers
    • 5.5.1.2.1. Pressure Ulcers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.1.3. Venous Leg Ulcers
    • 5.5.1.3.1. Venous Leg Ulcers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.1.4. Other Chronic Wounds
    • 5.5.1.4.1. Other Chronic Wounds market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Suture Market: End Use Estimates & Trend Analysis

• 6.1. Global Suture Market: End Use Dashboard
• 6.2. Global Suture Market: End Use Movement Analysis
• 6.3. Global Suture Market by End Use, Revenue
• 6.4. Hospitals and Clinics
  • 6.4.1. Hospitals and clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Ambulatory Surgery Center (ASC)
  • 6.5.1. Ambulatory Surgery Center (ASC) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Long-term Care Facilities
  • 6.6.1. Long-term care facilities market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Inpatient Rehabilitation Facility (IRF)
  • 6.7.1. Inpatient Rehabilitation Facility (IRF) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Skilled Nursing Facility (SNF)
  • 6.8.1. Skilled Nursing Facility (SNF) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Suture Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Global Suture Market: Distribution Channel Dashboard
• 7.2. Global Suture Market: Distribution Channel Movement Analysis
• 7.3. Global Suture Market by Distribution Channel, Revenue
• 7.4. Institutional Sales
  • 7.4.1. Institutional Sales market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Retail Sales
  • 7.5.1. Retail Sales market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Global Suture Market: Regional Estimates & Trend Analysis by Product, Wound Type, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates8and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.8. Recent Developments & Impact Analysis, By Key Market Participants
• 9.9. Company/Competition Categorization
• 9.10. Vendor Landscape
  • 9.10.1. List of key distributors and channel partners
  • 9.10.2. Key customers
  • 9.10.3. Key company market share analysis, 2024
  • 9.10.4. Medtronic
    • 9.10.4.1. Company overview
    • 9.10.4.2. Financial performance
    • 9.10.4.3. Product benchmarking
    • 9.10.4.4. Strategic initiatives
  • 9.10.5. Lotus Surgicals Pvt Ltd
    • 9.10.5.1. Company overview
    • 9.10.5.2. Financial performance
    • 9.10.5.3. Product benchmarking
    • 9.10.5.4. Strategic initiatives
  • 9.10.6. Dolphin Sutures
    • 9.10.6.1. Company overview
    • 9.10.6.2. Financial performance
    • 9.10.6.3. Product benchmarking
    • 9.10.6.4. Strategic initiatives
  • 9.10.7. CONMED Corporation
    • 9.10.7.1. Company overview
    • 9.10.7.2. Financial performance
    • 9.10.7.3. Product benchmarking
    • 9.10.7.4. Strategic initiatives
  • 9.10.8. Teleflex Incorporated
    • 9.10.8.1. Company overview
    • 9.10.8.2. Financial performance
    • 9.10.8.3. Product benchmarking
    • 9.10.8.4. Strategic initiatives
  • 9.10.9. Ethicon (Johnson & Johnson Services, Inc.)
    • 9.10.9.1. Company overview
    • 9.10.9.2. Financial performance
    • 9.10.9.3. Product benchmarking
    • 9.10.9.4. Strategic initiatives
  • 9.10.10. Smith + Nephew
    • 9.10.10.1. Company overview
    • 9.10.10.2. Financial performance
    • 9.10.10.3. Product benchmarking
    • 9.10.10.4. Strategic initiatives
  • 9.10.11. Integra LifeSciences Corporation
    • 9.10.11.1. Company overview
    • 9.10.11.2. Financial performance
    • 9.10.11.3. Product benchmarking
    • 9.10.11.4. Strategic initiatives
  • 9.10.12. Peter Surgical
    • 9.10.12.1. Company overview
    • 9.10.12.2. Financial performance
    • 9.10.12.3. Product benchmarking
    • 9.10.12.4. Strategic initiatives
  • 9.10.13. Healthium Medtech Limited
    • 9.10.13.1. Company overview
    • 9.10.13.2. Financial performance
    • 9.10.13.3. Product benchmarking
    • 9.10.13.4. Strategic initiatives
  • 9.10.14. Medline Industries, LP.
    • 9.10.14.1. Company overview
    • 9.10.14.2. Financial performance
    • 9.10.14.3. Product benchmarking
    • 9.10.14.4. Strategic initiatives
  • 9.10.15. Dynarex Corporation
    • 9.10.15.1. Company overview
    • 9.10.15.2. Financial performance
    • 9.10.15.3. Product benchmarking
    • 9.10.15.4. Strategic initiatives
  • 9.10.16. Corza Medical
    • 9.10.16.1. Company overview
    • 9.10.16.2. Financial performance
    • 9.10.16.3. Product benchmarking
    • 9.10.16.4. Strategic initiatives
  • 9.10.17. Advanced Medical Solutions Group plc
    • 9.10.17.1. Company overview
    • 9.10.17.2. Financial performance
    • 9.10.17.3. Product benchmarking
    • 9.10.17.4. Strategic initiatives
  • 9.10.18. Riverpoint Medical
    • 9.10.18.1. Company overview
    • 9.10.18.2. Financial performance
    • 9.10.18.3. Product benchmarking
    • 9.10.18.4. Strategic initiatives
  • 9.10.19. B. Braun SE
    • 9.10.19.1. Company overview
    • 9.10.19.2. Financial performance
    • 9.10.19.3. Product benchmarking
    • 9.10.19.4. Strategic initiatives
  • 9.10.20. Atramat
    • 9.10.20.1. Company overview
    • 9.10.20.2. Financial performance
    • 9.10.20.3. Product benchmarking
    • 9.10.20.4. Strategic initiatives
  • 9.10.21. DemeTECH Corporation
    • 9.10.21.1. Company overview
    • 9.10.21.2. Financial performance
    • 9.10.21.3. Product benchmarking
    • 9.10.21.4. Strategic initiatives

관련자료